How pre-URS tamsulosin use in pediatric patients may reduce repeat procedures
April 8th 2025“I would say the take-home message for this study is that prescribing tamsulosin for a week prior to an anticipated surgery that involves flexible ureteroscopy is a very simple practice that certainly is within standard of care within pediatric urology," says Kate H. Kraft, MD, MHPE, FACS, FAAP.
Expert discusses innovations in single-use ureteroscopes for stones
April 7th 2025"A lot of people are using [single-use ureteroscopes] nowadays, and part of it is because it really enhances our ability to provide guaranteed care, because we don't have to rely on the reusability of scopes," says Perry Xu, MD.
Naeem Bhojani, MD, discusses WATER III data on Aquablation vs enucleation for BPH
April 6th 2025"This study was an investigator initiated study, and what they wanted to do was a randomized trial for large prostates, so 80 to 180 grams, between Aquablation and prostate enucleation," says Naeem Bhojani, MD, FRCSC.
Neeraj Agarwal, MD, on talazoparib/enzalutamide efficacy by HRR gene mutation status
April 3rd 2025"We see the overall survival, whether it is [in] all-comers, in HRR gene mutation-positive patients, or in HRR gene [mutation]-negative patients or [those] who did not have mutations, the overall survival is about 45 to 47 months," says Neeraj Agarwal, MD, FACS.
Eugene Cone, MD, outlines potential impact of Expanded Access Program for rBCG
April 1st 2025“If it is as efficacious as it looks, we will have more patients who are getting effective standard of care treatment, not needing to go on to further treatment, not having recurrences, [having decreased] morbidity from repeated resections, and saving bladders in the process," says Eugene B. Cone, MD.
Dr Louise Kostos on the rapidly evolving prostate cancer treatment landscape
March 29th 2025“I think we now have really robust data showing that earlier treatment intensification with combination regimens does lead to improved survival for patients with metastatic hormone-sensitive prostate cancer," says Dr Louise Kostos.
Pain management disparities in kidney stones point to need for guidelines, experts say
March 28th 2025"For other health care professionals aiming to advocate for equitable changes within their system, it's really important to just start conversations about what you're noticing," says Hailey Frye.
What a long-term study of patients undergoing RARC reveals about upstaging
March 25th 2025“High risk, non–muscle invasive bladder cancer carries a significant risk of recurrence and progression. This emphasizes the need for careful patient selection, especially when we are considering bladder-sparing approaches," says Neeraja Tillu, MD.
Landon Trost, MD, on the impact of the FDA labeling changes for testosterone products
March 25th 2025"This now clarifies and substantiates the fact that there are not increased risks from a cardiovascular standpoint with [testosterone] therapy, at least at the doses studied," says Landon Trost, MD.